Amylyx Pharmaceuticals, Inc. technical analysis
Technical analysis of Amylyx Pharmaceuticals, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company headquartered in Cambridge, Massachusetts, founded in 2013, that engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions. The company's pipeline includes drug candidates in various stages of clinical testing, such as Avexitide (a GLP-1 receptor antagonist) for post-bariatric hypoglycemia and congenital hyperinsulinism, AMX0035 for Wolfram syndrome and progressive supranuclear palsy, and other compounds in development for rare diseases.
Description generated automatically from public sources; it may be inaccurate or out of date.
Amylyx Pharmaceuticals, Inc.: latest session data
Closing values for October 28, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
27.77 $
+1.06%
50 sessions
31.31 $
−10.34%
200 sessions
19.92 $
+40.88%
Session levels
s2
26.36
Support
s1
27.33
Support
pivot
27.82
Pivot
r1
28.80
Resistance
r2
29.29
Resistance
How to read it
In the October 28, 2026 session Amylyx Pharmaceuticals, Inc. closed lower at 28.07 $, −0.81% versus the previous session.
The price sits mixed against its moving averages: +1.06% against the 21-session average, −10.34% against the 50 and +40.88% against the 200.
The 14-period RSI reads 47.7, in neutral territory.
MACD stands at -0.530 against a signal line at -0.688: the histogram is positive (+0.159).
ADX reads 20.3, indicating weak directionality.
Levels computed on the latest session place supports at 27.33 and 26.36 $ and resistances at 28.80 and 29.29 $, around a pivot of 27.82.
The average daily range (ATR) is 1.419 $, or 5.05% of price.
Turnover was 1.1M shares, 80% of the 20-session average.
Over the last twelve months the price ranged between 12.44 and 41.14 $, and today stands −31.77% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the AMLX analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Amylyx Pharmaceuticals, Inc.
How is Amylyx Pharmaceuticals, Inc. analysed technically?
Technical analysis of Amylyx Pharmaceuticals, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Amylyx Pharmaceuticals, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Amylyx Pharmaceuticals, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Amylyx Pharmaceuticals, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.